How are semax and selank dosed and mixed?
500 mcg of Semax + Selank from a 10 mg vial mixed with 2 mL is 10 units on a U-100 syringe.
Every vial at a glance. Pick a cell to draw it on the syringe.
| Vial | 1 mL of water | 2 mL of water | 3 mL of water |
|---|---|---|---|
| 5 mg | 5 mg/mL: 250 mcg is 5 units, 400 mcg is 8 units, 500 mcg is 10 units | 2.5 mg/mL: 250 mcg is 10 units, 400 mcg is 16 units, 500 mcg is 20 units | 1.667 mg/mL: 250 mcg is 15 units, 400 mcg is 24 units, 500 mcg is 30 units |
| 10 mg | 10 mg/mL: 250 mcg is 2.5 units, 400 mcg is 4 units, 500 mcg is 5 units | 5 mg/mL: 250 mcg is 5 units, 400 mcg is 8 units, 500 mcg is 10 units | 3.333 mg/mL: 250 mcg is 7.5 units, 400 mcg is 12 units, 500 mcg is 15 units |
The Peptogen Semax leaflet gives, for intellectual-mnestic disorders with vascular brain lesions, 2 to 3 drops of the 0.1% drops in each nasal passage 4 times a day for 10 to 14 days (800 to 8,000 mcg a day).1
Vial strengths, mixing and syringe marks
500 mcg of Semax + Selank from a 10 mg vial mixed with 2 mL is 10 units on a U-100 syringe.
500 mcg of Semax + Selank from a 10 mg vial mixed with 2 mL is 10 units on a U-100 syringe.
Of the people who logged semax, 75% set up a 10 mg vial and 15% a 5 mg vial; for selank, 83% set up a 10 mg vial.13 For mixing, 45% of the people who logged semax and 45% of those who logged selank set up 10 mg with 2 mL.13 The worked example and calculator are set to 10 mg with 2 mL and 500 mcg; 36% of the people who logged semax and 36% of those who logged selank set up 500 mcg, each on its own, not as a blend.13
None of the sources cited here gives a water volume for mixing either powder; the registered products are ready-made nasal drops. A laboratory paper on seized preparations (Vanhee), whose samples contained Selank and Semax, reports that an online search showed research peptides of this kind sold as lyophilized powder for injection or in nasal sprays.2 On a U-100 syringe, 100 units are 1 mL.3
Products and routes
The Peptogen leaflet for Semax gives 0.1% nasal drops in 3 mL, with 50 mcg a drop (500 mcg a drop in the 1% drops).1 It says the drops are applied intranasally, with not more than 2 to 3 drops in each nasal passage.1 For a moderate stroke, the leaflet gives 2 to 3 drops of the 1% drops in each nostril 3 to 4 times a day; for a severe stroke, 3 to 4 drops in each nostril 4 to 5 times a day.1 No label or human trial cited here states an injection route or site for either peptide.
What the human trials used
The trials cited here give a dose only for semax; for selank the only dose located is in a Russian register entry.
| Trial | Dose and schedule | People | Length |
|---|---|---|---|
| Gusev 1997, semax | Daily 12 mg (moderate stroke) or 18 mg (severe stroke), the doses with the best effect | 30 in the acute period of hemispheric ischemic stroke given semax within combined intensive therapy, 80 controls on conventional therapy | Courses of 5 and 10 days4 |
| Gusev 2018, semax | Standard regimen 6,000 mcg a day | One hundred and ten after ischemic stroke, in early and late rehabilitation groups, each split into semax+ and semax- subgroups | 2 courses of 10 days, 20-day interval5 |
| Serdiuk 2007, semax 1% intranasal | 12 mg a day | 27 with motor neuron disease | Two 10-day courses, 2-week break6 |
| Polunin 2000, semax | Nasal drops (group 1) or endonasal electrophoresis (group 2); no dose stated | People with optic nerve disease in 3 groups, group 3 a control; numbers not stated | Not stated7 |
| Zozulia 2008, selank | Not stated | People with generalized anxiety disorder and neurasthenia: 30 on selank, 32 on medazepam | Not stated8 |
| Medvedev 2014, selank | Not stated | 60 in total with phobic-anxiety and somatoform disorders, selank compared with phenazepam | Not stated9 |
| Medvedev 2015, selank | Not stated | People with anxiety-phobic, hypochondriac and somatoform disorders: 40 on selank plus phenazepam, 30 on phenazepam alone | Not stated10 |
| Uchakina 2008, selank | Not stated | People with generalized anxiety disorder and neurasthenia; number not stated | 14 days11 |
What people log
Of the people who logged semax, 36% set up a 500 mcg dose and 10% a 400 mcg dose.13 For selank, 36% logged 500 mcg and 17% logged 250 mcg.13 Of the people who logged semax, 72% recorded under the skin and 21% nasal; for selank it was 76% and 22%.13
Storage
The Semax leaflet says to store the drops in the dark at no more than 10 °C and not to freeze.1 None of the sources cited here gives storage for the powder or how long a mixed vial keeps.
Frequently asked questions
Is there an approved label for semax or selank?
A DailyMed search for semax and selank found no labels. Apart from the Peptogen manufacturer leaflet for Semax, the only labels located were Russian register entries for Semax and Selank drops; European, Australian and UK regulators were not searched. The FDA agenda for its July 23-24, 2026 Pharmacy Compounding Advisory Committee lists Semax-related bulk drug substances as being considered for inclusion on the list of bulk drug substances that can be used to compound drug products under section 503A.12
Have semax and selank been studied together?
No human trial of semax and selank together was located; a ClinicalTrials.gov search showed no semax studies and no studies of the selank peptide.
What do the sources say about safety?
The Semax leaflet lists as contraindications hypersensitivity to its components, children under 7 (under 18 in ophthalmic and neurosurgical practice; no clinical studies have been conducted), pregnancy and lactation (no clinical studies have been conducted), acute psychotic states, disorders accompanied by anxiety, and a history of cramps.1 The leaflet says prolonged use may cause a mild irritation of the nasal mucosa; no safety statement for Selank was quoted for this guide.1
How the logged figures are counted
Milligram app dose logs, aggregated and anonymous, the 90 days to 17 November 2026. Each figure is a share of people who set up or logged the item, and each share is of at least 50 people.
References
- Peptogen (Semax instruction leaflet). INTERNATIONAL NON-PROPRIETARY NAME (INN): methionyl-glutamyl-histidyl-. cdn.shopify.com
- PubMed. The occurrence of putative cognitive enhancing research peptides in seized pharmaceutical preparations: An incentive for controlling agencies to prepare for future encounters of the kind. 2020. pubmed.ncbi.nlm.nih.gov
- MedlinePlus (US National Library of Medicine). Giving an insulin injection: MedlinePlus Medical Encyclopedia. medlineplus.gov
- PubMed. [Effectiveness of semax in acute period of hemispheric ischemic stroke (a clinical and electrophysiological study)]. 1997. pubmed.ncbi.nlm.nih.gov
- PubMed. [The efficacy of semax in the tretament of patients at different stages of ischemic stroke]. 2018. pubmed.ncbi.nlm.nih.gov
- PubMed. [The study of chronic partial denervation and quality of life in patients with motor neuron disease treated with semax]. 2007. pubmed.ncbi.nlm.nih.gov
- PubMed. [Evaluation of therapeutic effect of new Russian drug semax in optic nerve disease]. 2000. pubmed.ncbi.nlm.nih.gov
- PubMed. [Efficacy and possible mechanisms of action of a new peptide anxiolytic selank in the therapy of generalized anxiety disorders and neurasthenia]. 2008. pubmed.ncbi.nlm.nih.gov
- PubMed. [A comparison of the anxiolytic effect and tolerability of selank and phenazepam in the treatment of anxiety disorders]. 2014. pubmed.ncbi.nlm.nih.gov
- PubMed. [Optimization of the treatment of anxiety disorders with selank]. 2015. pubmed.ncbi.nlm.nih.gov
- PubMed. [Immunomodulatory effects of selank in patients with anxiety-asthenic disorders]. 2008. pubmed.ncbi.nlm.nih.gov
- US FDA. July 23-24, 2026 Pharmacy Compounding Advisory Committee (PCAC) Meeting. fda.gov
- Milligram app dose logs, aggregated and anonymous, the 90 days to 17 November 2026. Each figure is a share of people who set up or logged the item, and each share is of at least 50 people. How these figures are counted